Evidence map›Paper›PMID 40431349›Full record

ReviewNutrients2025

Moderate Wine Consumption and Gastrointestinal Diseases.

Patrizia Restani, Chiara Di Lorenzo, Arina Oana Antoce, Marcos Araujo, Corinne Bani, Francesca Mercogliano, Jean-Claude Ruf, Rena I Kosti, Pierre-Louis Teissedre

Abstract readReview
In one paragraph

Review in Nutrients, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Patrizia RestaniFaculty of Pharmacy, Università degli Studi di Milano, 20133 Milano, Italy.ORCID 0000-0002-3008-5987
Chiara Di LorenzoCRC "Innovation for Well-Being and Environment", Università degli Studi di Milano, 20122 Milano, Italy.ORCID 0000-0002-2798-8720
Arina Oana AntoceDepartment of Bioengineering of Horti-Viticultural Systems, University of Agronomic Sciences and Veterinary Medicine of Bucharest, 011464 Bucharest, Romania.ORCID 0000-0002-7342-1741
Marcos AraujoOIV-International Organisation of Vine and Wine, 21000 Dijon, France.
Corinne BaniDepartment of Pharmacological and Biomolecular Sciences, Università degli Studi di Milano, 20133 Milano, Italy.ORCID 0000-0002-9736-8746
Francesca MercoglianoDepartment of Pharmacological and Biomolecular Sciences, Università degli Studi di Milano, 20133 Milano, Italy.ORCID 0000-0002-1785-0437
Jean-Claude RufOIV-International Organisation of Vine and Wine, 21000 Dijon, France.
Rena I KostiDepartment of Nutrition and Dietetics, School of Physical Education, Sports and Dietetics, University of Thessaly, 42132 Trikala, Greece.ORCID 0000-0001-7915-6064
Pierre-Louis TeissedreUniversité de Bordeaux, Bordeaux INP, INRAE, OENO, UMR 1366, ISVV, F-33140 Villenave d'Ornon, France.ORCID 0000-0002-0115-5456

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

By conducting a narrative review of the scientific literature, the authors of this study sought to verify whether there were sufficient data to answer the following question: "Can wine positively or negatively influence the incidence and severity of disorders associated with gastrointestinal (GI) diseases?". In this review, most of the studies considered tested different alcoholic beverages (other than wine), not always reporting in the conclusions the possible difference in the extent of symptoms. Although alcohol certainly plays a central role in influencing the oesophageal and gastric environment, no studies evaluating the role of alcohol as such were included, since the aim of the review was to understand whether wine can be moderately consumed by patients with gastrointestinal diseases. The analysis of studies selected from the main reference databases indicates that even moderate wine consumption can be a source of discomfort in subjects with the GI diseases included in this review (gastritis and gastroesophageal disease, gastrointestinal motility, inflammatory bowel disease, irritable bowel syndrome, and microscopic colitis). This does not mean that a certain percentage of patients cannot tolerate moderate amounts of alcoholic beverages; however, discussion with the family doctor or specialist is essential to identify the correct diet in which to include or exclude the consumption of wine. One of the limitations of this review is the low number of studies available, at least for some of the pathologies considered. It is important to emphasise, however, that some selected epidemiological studies, which include many subjects (even over 100,000), can provide useful information from a scientific point of view.

Indexed as

Alcohol DrinkingGastrointestinal DiseasesWineHumansalcoholic beveragesgastroesophageal disease or GERDgastrointestinal diseasesinflammatory bowel disease or IBDirritable bowel syndrome or IBSwine

Identifiers

PMID40431349
PMCPMC12114267

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.